The LINX Reflux Management System is a surgically implanted expandable ring of magnetic titanium beads used to treat gastroesophageal reflux disease (GERD). It augments a defective lower esophageal sphincter (LES) using the magnetic attraction between adjacent beads to keep the ring and LES closed before and after swallowing.
The LINX was developed in the 2000’s and has been FDA approved since 2012 for treating patients who continue to have chronic GERD symptoms despite maximum medical therapy. The surgical procedure is studied and demonstrates good long term relief of reflux symptoms, superior improvement of acid regurgitation, resolution of reflux related problems, and good long term patient satisfaction. (1) The most common side effect is dysphagia or difficulty swallowing. It is often temporary and a normal part of the healing process.
Candidates for LINX include individuals who have failed medical management, choose to manage their GERD with surgery to stop or reduce medical therapy, have complications related to GERD such as Barrett’s esophagus, or have extra-esophageal manifestations such as asthma, hoarseness, cough or aspiration.
Additionally, LINX is indicated for patients with or without hiatal hernias. Your hiatal hernia can be repaired during the LINX procedure.
A comparison of the LINX with other procedures can be found on our pros and cons page.
- Ganz RA, Long Term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux, Clinical Gastroenterology and Hepatology, May 2016.